Comments feed https://evgenykuznetsov.org/en/posts/2021/iqvia/ on DIMV - Comments feed Hugo -- gohugo.ioenevgeny@kuznetsov.md (Evgeny Kuznetsov) evgeny@kuznetsov.md (Evgeny Kuznetsov)Thu, 08 Jul 2021 23:44:16 +0300 Programming Channel shared https://ap.brid.gy/convert/web/https://newsmast.community/users/programming/statuses/115483306170120417/activity Mon, 03 Nov 2025 02:03:32 +0000 Programming Channel https://ap.brid.gy/convert/web/https://newsmast.community/users/programming/statuses/115483306170120417/activity_https://evgenykuznetsov.org/en/posts/2021/iqvia/_1951757 a post by Evgeny Kuznetsov

You thought Signant was the only company in clinical trials that decided not to go over to the new century, huh? Enter one of the world’s largest CROs.

This Web site is best viewed with Internet Explorer 8 and in 1024x768 resolution.

– Copyright © 2021 IQVIA

It would be funny if it wasn’t so sad.

]]>